找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Bioequivalence Requirements in Various Global Jurisdictions; Isadore Kanfer Book 2017 American Association of Pharmaceutical Scientists 20

[复制链接]
查看: 15242|回复: 52
发表于 2025-3-21 16:45:28 | 显示全部楼层 |阅读模式
期刊全称Bioequivalence Requirements in Various Global Jurisdictions
影响因子2023Isadore Kanfer
视频video
发行地址Combines BE (bioequivalence) standards from across the world into a single reference source.Provides essential information for market approval of generic products.Attempts to harmonize country specifi
学科分类AAPS Advances in the Pharmaceutical Sciences Series
图书封面Titlebook: Bioequivalence Requirements in Various Global Jurisdictions;  Isadore Kanfer Book 2017 American Association of Pharmaceutical Scientists 20
影响因子.Although the Bioequivalence (BE) requirements in many global jurisdictions have much in common, differences in certain approaches and requirements such as definitions and terms, choice of comparator (reference) product, acceptance criteria, fasted and fed studies, single and multi-dose studies, biowaivers and products not intended for absorption into the systemic circulation (locally acting medicines and dosage forms), amongst others, provide food for thought that standardisation should be a high priority objective in order to result in a harmonized international process for the market approval of products using BE. An important objective of .Bioequivalence Requirements. in Various Global Jurisdictions is to attempt to gather the various  BE requirements used in different global jurisdictions to provide a single source of relevant information. This information from, Brazil, Canada, China, European Union, India, Japan, MENA, Russia South Africa, the. USA and WHO will be of value to drug manufacturers, regulatory agencies, pharmaceutical scientists and related health organizations and governments around the world in the quest to harmonize regulatory requirements for the market appro
Pindex Book 2017
The information of publication is updating

书目名称Bioequivalence Requirements in Various Global Jurisdictions影响因子(影响力)




书目名称Bioequivalence Requirements in Various Global Jurisdictions影响因子(影响力)学科排名




书目名称Bioequivalence Requirements in Various Global Jurisdictions网络公开度




书目名称Bioequivalence Requirements in Various Global Jurisdictions网络公开度学科排名




书目名称Bioequivalence Requirements in Various Global Jurisdictions被引频次




书目名称Bioequivalence Requirements in Various Global Jurisdictions被引频次学科排名




书目名称Bioequivalence Requirements in Various Global Jurisdictions年度引用




书目名称Bioequivalence Requirements in Various Global Jurisdictions年度引用学科排名




书目名称Bioequivalence Requirements in Various Global Jurisdictions读者反馈




书目名称Bioequivalence Requirements in Various Global Jurisdictions读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 20:13:38 | 显示全部楼层
Verkaufsförderung im Kulturbereichto which the . bioequivalence (reference standard) and, in some instances, the . bioequivalence of the applicant’s product is compared are listed by the US-FDA in its publication . (the Orange Book). The Orange Book identifies all prescription and over-the-counter (OTC) drug products approved for ma
发表于 2025-3-22 03:21:44 | 显示全部楼层
发表于 2025-3-22 07:23:42 | 显示全部楼层
发表于 2025-3-22 11:49:03 | 显示全部楼层
Bioequivalence Requirements in Various Global Jurisdictions
发表于 2025-3-22 14:01:57 | 显示全部楼层
发表于 2025-3-22 18:06:03 | 显示全部楼层
,Theoriebezüge zur Kundenauswahl,rding to IMS Health, GDPs are expected to account for 52% of global pharmaceutical spending in 2018 compared to 35% for branded drug products [2]. Moreover, the impact of GDPs on drug spending will make even more impact in the coming years, resulting from the fact that small molecule patent expirati
发表于 2025-3-22 21:48:23 | 显示全部楼层
,Theoriebezüge zur Kundenauswahl,ucts, chlorpromazine, digitoxin, digoxin, lithium carbonate, quinidine, tetracycline, and tolbutamide in the Indian Pharmacopoeia in 1985, [1] initiated the process of framing legislation for regulatory requirements of BE studies. After this phase (3 years), BE studies became mandatory for all new d
发表于 2025-3-23 03:54:58 | 显示全部楼层
发表于 2025-3-23 06:22:41 | 显示全部楼层
https://doi.org/10.1007/978-3-322-81424-1cal Industry-League of Arab States in 2014. The new guidance has been approved by health regulatory authorities’ representatives from MENA Region including Kingdom of Saudi Arabia, Kingdom of Jordan, Republic of Sudan, Republic of Algeria, Republic of Libya, Republic of Iraq, Republic of Egypt, Sult
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-30 14:18
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表